300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Real Estate
Mobile Apps
Finance
Sporting Goods
Manufacturing
FinTech
Social Media
Music
Franchise
Internet
Mobile Advertising
Art
Android
Impact
Proptech
Hardware
Transportation
Biotech
Enterprise
Sustainability
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Croatia
Togo
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Nepal
Turkey
Liberia
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Armenia
Guernsey
Cameroon
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Ireland (November 2026)

The most active venture capital funds investing in Ireland Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Ireland Medical startup companies. Find investors to raise a Seed, Series A or Venture - Series Unknown round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Enterprise Ireland
VC Fund
47 Ireland, United States, United Kingdom Seed, Venture - Series Unknown, Grant Software, Health Care, Information Technology $26k–$8.2M
SOSV
VC Fund
11 United States, China, Canada Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software $25k–$5M
Elkstone Capital Partners
VC Fund
11 Ireland, United Kingdom, United States Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Health Care $797k–$18M
Western Development Commission
VC Fund
10 Ireland, United States Seed, Venture - Series Unknown, Series A Health Care, Medical Device, Biotechnology $702k–$17M
Atlantic Bridge
VC Fund
10 United States, Ireland, United Kingdom Series A, Series B, Seed Software, Artificial Intelligence, Information Technology $1.1M–$62M
Irrus Investments
VC Fund
9 Ireland, Sweden, United States Seed, Venture - Series Unknown, Series A Health Care, Medical Device, Biotechnology $879k–$24M
HBAN
VC Fund
9 Ireland, United Kingdom, United States Seed, Venture - Series Unknown Health Care, Software, Medical Device $375k–$7.3M
AIB Seed Capital Fund
VC Fund
9 Ireland, United States, Jersey Seed, Series A Software, Health Care, Medical $549k–$8.1M
Furthr VC
VC Fund
8 Ireland Seed, Venture - Series Unknown Software, Medical Device, Medical $753k–$17M
HBAN Medtech Syndicate
VC Fund
8 Ireland Seed, Series B Medical Device, Medical, Health Care $1.3M–$11M
Act Venture Capital
VC Fund
6 Ireland, United States, United Kingdom Seed, Series A Software, Artificial Intelligence, Information Technology $1M–$13M
Fountain Healthcare Partners
VC Fund
5 Ireland, United States, France Series A, Series B, Series C Health Care, Biotechnology, Medical $4.1M–$110M
Faber
VC Fund
5 Portugal, Germany, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $121k–$25M
Business Venture Partners
VC Fund
5 Ireland, The Netherlands, Luxembourg Seed, Venture - Series Unknown Health Care, Information Technology, Medical $665k–$7.1M
Kernel Capital
VC Fund
5 Ireland, United Kingdom, France Venture - Series Unknown, Seed Software, Information Technology, Health Care $549k–$12M
NDRC
VC Fund
4 Ireland, United States, United Kingdom Seed, Pre-Seed, Convertible Note Software, Information Technology, E-Commerce
Seroba Life Sciences
VC Fund
4 Ireland, United States, United Kingdom Series A, Series B Health Care, Biotechnology, Medical $4.6M–$105M
First Citizens Innovation Banking
VC Fund
3 United States, Canada, United Kingdom Debt Financing, Series B, Series A Software, Health Care, Biotechnology $2M–$100M
Enterprise Equity
VC Fund
3 Ireland, United States, United Kingdom Seed, Series B Software, Information Technology, Health Care $549k–$7.5M
SciFounders
VC Fund
3 United States, Ireland, United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Medical $400k–$21M
Ascentifi
VC Fund
3 Ireland Seed, Series A, Venture - Series Unknown Health Care, Medical Device, Medical $2.3M–$34M
Medtech Syndicate Nominee
VC Fund
3 Ireland Seed, Series A Medical, Health Care, Medical Device
Diagnostics Polymers
VC Fund
3 Ireland Convertible Note, Venture - Series Unknown Medical, Big Data, Health Care $1.2M–$1.9M
SVG Ventures
VC Fund
2 Canada, United States, Australia Non-Equity Assistance, Seed, Pre-Seed AgTech, Agriculture, Farming $16k–$4.7M
EIT Health
VC Fund
2 United Kingdom, Spain, Ireland Grant, Pre-Seed, Seed Health Care, Medical Device, Medical $27k–$1.7M
Boole
VC Fund
2 Ireland Seed Health Care, Medical Device, Medical $2M–$4.2M
Artis Ventures
VC Fund
2 United States, United Kingdom, India Series A, Series B, Seed Health Care, Biotechnology, Software $2.1M–$127M
Lynett Capital
VC Fund
2 United States, Kenya, Nigeria Seed, Series A, Pre-Seed FinTech, SaaS, Software $230k–$49M
Life Sciences Fund Amsterdam
VC Fund
2 Ireland, United States, The Netherlands Series A, Private Equity Medical, Health Care, Biotechnology $11M–$61M
Glanzmann Enterprises
VC Fund
2 Ireland Series A Medical, Health Care, Medical Device
European Investment Bank
VC Fund
2 France, Germany, Spain Debt Financing, Post-IPO Debt, Venture - Series Unknown Energy, Biotechnology, Health Care $8.7M–$587M
Partisan Management Group
VC Fund
2 United States, Ireland Series A, Series B Medical, Health Care, Biotechnology $6.1M–$50M
Foresight Group
VC Fund
2 United Kingdom, United States, Ireland Venture - Series Unknown, Private Equity, Seed Software, Information Technology, Manufacturing $648k–$8.3M
Frazier Healthcare Partners
VC Fund
2 United States, Canada, Ireland Series B, Series A, Post-IPO Equity Biotechnology, Health Care, Therapeutics $10M–$200M
Gotzee Ltd
VC Fund
2 Ireland Venture - Series Unknown Medical, Big Data, Health Care $1.2M–$1.9M
Oyster Capital Partners
VC Fund
2 Ireland, United Kingdom, United States Series A, Seed, Venture - Series Unknown Software, SaaS, Health Care $1.2M–$97M
HealthCap
VC Fund
2 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $6M–$92M
Boole Investment Syndicate
VC Fund
2 Ireland, Estonia, United States Seed, Series A Biotechnology, SaaS, Software $623k–$2.2M
DHKN
VC Fund
2 Ireland Venture - Series Unknown Medical, Health Care, Medical Device $6.9M–$7.1M
Delta Partners
VC Fund
2 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $812k–$6.6M
Cantor Fitzgerald
VC Fund
2 United States, Canada, Ireland Post-IPO Equity, Debt Financing, Series B Biotechnology, Energy, Software $6.4M–$195M
Pareto Holdings
VC Fund
2 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Artificial Intelligence, FinTech $125k–$35M
Gaingels
VC Fund
2 United States, Canada, United Kingdom Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Health Care $72k–$35M
Keiretsu Forum Northwest
VC Fund
1 United States, Spain, Canada Series A, Seed Health Care, Software, Biotechnology $507k–$8M
Street Capital
VC Fund
1 Ireland, United States Seed Medical, Automotive, Biotechnology
Kreos Capital
VC Fund
1 United Kingdom, Germany, United States Debt Financing, Series B, Post-IPO Debt Biotechnology, Health Care, Software
Moffett Investment Holdings
VC Fund
1 Ireland Series A, Series B Medical, Health Care, Biotechnology
Venturewave Capital
VC Fund
1 Ireland, Egypt, United Kingdom Seed, Series A Health Care, Education, E-Commerce
Inventages Venture Capital Investment Inc.
VC Fund
1 United States, United Kingdom, Canada Series A, Series B Biotechnology, Health Care, Therapeutics
EarlyBird
VC Fund
1 Germany, Ireland, Romania Seed, Series A, Series B Financial Services, FinTech, Health Care $3.3M–$25M
Access all 188 VC funds in Ireland Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 47 investments in Ireland Medical startups

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Grant
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 895
  • Round size: Seed $399k–$3.2M; Grant $26k–$5.5M; Venture - Series Unknown $560k–$8.2M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $1.2M in 2021

Portfolio highlights

  • Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
  • Amethyst Care — Amethyst Care is a startup that creates an AI-powered voice assistant for those with mobility difficulties.
  • EstateMin — EstateMin provides software for law firms handling estate planning, trust administration, probate, and estate administration. Its platform supports client intake, case workflows, document organization, asset and liability tracking, and case progress visibility through a centralized dashboard. A client portal lets clients and executors submit information and documents. The platform also offers AI-supported case review and integrates with Clio.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 11 investments in Ireland Medical startups

SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 3821
  • Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $306M in 2023

Portfolio highlights

  • Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
  • Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
  • Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
Show all investments...

Elkstone Capital Partners
VC Fund · Dublin, Dublin, Ireland · 11 investments in Ireland Medical startups, 9 in the past 12 months

Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora. The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellent investment performance.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 98
  • Round size: Seed $797k–$5.8M; Series A $5.5M–$18M; Venture - Series Unknown $1.1M–$7.8M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $108M in 2023

Portfolio highlights

  • Entity — Entity's purpose is shape the future of web gaming by leveraging emerging technologies and maximizing the browser's capabilities. Our next-generation gaming hub, scheduled to arrive in 2027, will be a global place for players to discover, connect, and play together.
  • ZeroRisk.io — ZeroRisk.io's Merchant Management Platform delivers advanced compliance and cybersecurity solutions. Gain insights, mitigate risks, and drive revenue. Book a demo today.
  • Full Health Medical — Full Health Medical patient empowerment tools that improve prevention healthcare are part of the healthcare ecosystem. FHM provides reliable digital innovation, designed by healthcare professionals that are keen to help patients live a healthy life, in response to a national scarcity of healthcare providers, the development of chronic disease, anda lack of transparency at the patient level. People provide lifetime access to preventive care healthcare across screening, diagnostics, education, treatment, and a record of their journey driven technology provides lifetime access to preventative healthcare custom designed at every step screening, diagnostics, education, and action plans that motivate individuals to address risks before they develop health problems.
Show all investments...

Western Development Commission
VC Fund · Ballaghaderreen, Roscommon, Ireland · 10 investments in Ireland Medical startups

Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Ireland, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $702k–$3.9M; Series A $2.2M–$11M; Venture - Series Unknown $753k–$17M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
  • Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Show all investments...

Atlantic Bridge
VC Fund · Dublin, Dublin, Ireland · 10 investments in Ireland Medical startups

Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up and exploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto. Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies. Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: United States, Ireland, United Kingdom

Investor stats

  • Total investments: 155
  • Round size: Seed $1.1M–$7.5M; Series A $4.5M–$26M; Series B $10M–$62M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $97M in 2021

Portfolio highlights

  • GloNav — GloNav develops global positioning system and satellite navigation technologies and products for the wireless handset and mobile consumer electronics device markets. It offers global positioning system radio frequency integrated circuits and single chip assisted-global positioning systems, which are used for low dropout tracking and cellularhandset integration. The company was founded in 2006 and is based in Newport Beach, California. It has locations in the United States, the United Kingdom, Ireland, and Taiwan. As of January 2008, GloNav, Inc. operates as a subsidiary of NXP B.V.
  • Mindgard — Mindgard is the leading provider of AI Red Teaming solutions.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Show all investments...

Irrus Investments
VC Fund · Limerick, Limerick, Ireland · 9 investments in Ireland Medical startups

Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Ireland, Sweden, United States

Investor stats

  • Total investments: 34
  • Round size: Seed $879k–$4.7M; Series A $2.2M–$9.2M; Venture - Series Unknown $1.2M–$24M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
  • Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
Show all investments...

HBAN
VC Fund · Dublin, Dublin, Ireland · 9 investments in Ireland Medical startups

HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical Device
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 74
  • Round size: Seed $623k–$3.6M; Venture - Series Unknown $375k–$7.3M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $11M in 2018

Portfolio highlights

  • Movetru — Movetru a wearable device that aims to reduce injury and enhance rehabilitation.
  • Glitch Ads — GlitchAds intends to democratize advertising by "leveraging" adverts and artificial intelligence.
  • Change by Degrees — Change by Degrees is closed. While our purpose is to give every person on the planet sustainability as a superpower, policy changes at European level and
Show all investments...

AIB Seed Capital Fund
VC Fund · Dublin, Dublin, Ireland · 9 investments in Ireland Medical startups

The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012. The Fund has a total of €30m under management with AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success. The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies. The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise. Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin. Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Ireland, United States, Jersey

Investor stats

  • Total investments: 49
  • Round size: Seed $549k–$3.6M; Series A $1.1M–$8.1M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

Furthr VC
VC Fund · Dublin, Dublin, Ireland · 8 investments in Ireland Medical startups

We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.

Show more...

Investment focus

  • Industry: Software, Medical Device, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 31
  • Round size: Seed $797k–$6.3M; Venture - Series Unknown $753k–$17M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $36M in 2019

Portfolio highlights

  • WrxFlo — Optimise your supply chain with WrxFlo digitalisation platform. Unlock data-driven insights, automate compliance, and drive supply chain sustainability.
  • Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Show all investments...

HBAN Medtech Syndicate
VC Fund · 8 investments in Ireland Medical startups

HBAN Medtech Syndicate

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Seed, Series B
  • Geography: Ireland

Investor stats

  • Total investments: 13
  • Round size: Seed $1.3M–$11M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Act Venture Capital
VC Fund · Dublin, Dublin, Ireland · 6 investments in Ireland Medical startups

Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth. We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internet and mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach. Act is based in Dublin, Ireland. Our most recent funds are supported by the European Investment Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 166
  • Round size: Seed $1M–$5M; Series A $2.3M–$13M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $146M in 2022

Portfolio highlights

  • Ubotica — Ubotica delivers live maritime intelligence powered by Orbital AI, using satellites and sensors to predict risk, confirm threats and deliver actionable evidence.
  • Entity — Entity's purpose is shape the future of web gaming by leveraging emerging technologies and maximizing the browser's capabilities. Our next-generation gaming hub, scheduled to arrive in 2027, will be a global place for players to discover, connect, and play together.
  • Fresco — Fresco powers connected cooking experiences for appliance brands, enabling faster launches, lower R&D costs, and continuous innovation.
Show all investments...

Fountain Healthcare Partners
VC Fund · Dublin, Dublin, Ireland · 5 investments in Ireland Medical startups

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Ireland, United States, France

Investor stats

  • Total investments: 57
  • Round size: Series A $6.3M–$35M; Series B $5.5M–$68M; Series C $4.1M–$110M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $140M in 2019

Portfolio highlights

  • Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
  • Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
  • Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
Show all investments...

Faber
VC Fund · Lisbon, Lisboa, Portugal · 5 investments in Ireland Medical startups, 8 in the past 12 months

Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively help founders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies. Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Portugal, Germany, United Kingdom

Investor stats

  • Total investments: 101
  • Round size: Seed $679k–$5.7M; Pre-Seed $121k–$3M; Series A $2.5M–$25M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — raised $34M in 2024

Portfolio highlights

  • Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
  • Photon Bridge — Photon Bridge develops multi-wavelength digital light engines and photonic integration platforms for dense wavelength division multiplexing in data center and telecom optics. The company focuses on external laser sources, tunable laser assemblies, and transmit optical sub-assemblies for co-packaged optics, optical I/O, and high-density optical interconnects. Photon Bridge uses a patented cantilever waveguide and photonics interposer approach to integrate III–V light sources with silicon photonics using OSAT-based manufacturing flows. Its architectures target high channel density, wavelength stability, and simplified packaging for AI data centers, hyperscale cloud, and high-performance computing infrastructure. Photon Bridge also designs scalable photonic integration solutions that support applications in lidar, spectral sensing, and next-generation PIC-based optical systems.
  • Helix Robotics — We are building the first commercial soft manipulator
Show all investments...

Business Venture Partners
VC Fund · Dublin, Dublin, Ireland · 5 investments in Ireland Medical startups

Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. The team works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits. Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors. In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland, The Netherlands, Luxembourg

Investor stats

  • Total investments: 35
  • Round size: Seed $665k–$4.7M; Venture - Series Unknown $730k–$7.1M
  • Lead/follow: 60% lead, 40% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Swaay — Swaay prints beverage cans. Traditional offset can printing needs metal plates and orders in the hundreds of thousands, so a new design takes months. Swaay prints digitally instead, so there are no plates and no big minimum order. Brands can print anywhere from 1,000 cans up. Swaay runs this through a network of local printing hubs, so a design can go from artwork to shelf in weeks rather than quarters.
  • Oranda Therapeutics — Oranda Therapeutics: ensuring sustainable, affordable access to rare disease medicines across Europe through high-quality established treatments.
  • The Corporate Governance Institute — Diploma Certification for Board Directors. University accredited Courses for existing and aspiring Directors. Qualify as a Director.
Show all investments...

Kernel Capital
VC Fund · Cork, Cork, Ireland · 5 investments in Ireland Medical startups

Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generate revenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Venture - Series Unknown, Seed
  • Geography: Ireland, United Kingdom, France

Investor stats

  • Total investments: 96
  • Round size: Seed $549k–$2M; Venture - Series Unknown $841k–$12M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2013

Portfolio highlights

  • Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
  • preico — Preico Network empowers Web2 and Web3 developers to create, own, and monetize crypto-native AI models on a decentralized platform
  • Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Show all investments...

NDRC
VC Fund · Dublin, Dublin, Ireland · 4 investments in Ireland Medical startups

NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 110
  • Lead/follow: no public data

Portfolio highlights

  • Nory AI — Revolutionise your restaurant with Nory's restaurant management software. Streamline operations, boost profits, and enhance decision-making in one platform.
  • Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.
  • Ceartas DMCA — Ceartas is the leader in piracy protection for creators, brands & enterprise. Powered by AI, we have the highest removal rate in the industry
Show all investments...

Seroba Life Sciences
VC Fund · Dublin, Dublin, Ireland · 4 investments in Ireland Medical startups

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 49
  • Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $108M in 2017

Portfolio highlights

  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Show all investments...

First Citizens Innovation Banking
VC Fund · Santa Clara, California, United States · 3 investments in Ireland Medical startups

First Citizens Innovation Banking works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven international operations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Debt Financing, Series B, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 846
  • Round size: Series A $4M–$26M; Series B $8M–$50M; Debt Financing $2M–$100M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Zogenix — Therapeutic Solutions for CNS Disorders and Rare Diseases
  • Capitolis — Capitolis is the technology company helping to create safer and more vibrant financial markets by unlocking capital constraints and enabling greater access to more diversified capital and investment opportunities. Rooted in advanced technology and deep financial expertise, Capitolis powers groundbreaking financial solutions that drive growth forglobal and regional banks – and institutional investors alike.
  • Torch Systems — Ultra early fire detection and analytics platform. Built for communities, enterprises, and the environment
Show all investments...

Enterprise Equity
VC Fund · Dundalk, Louth, Ireland · 3 investments in Ireland Medical startups

Enterprise Equity (or EEVC) has an excellent reputation for providing capital to early stage and expanding business throughout Ireland. With the advantage of having a strong regional presence in Cork, Galway and Dundalk – in addition to Dublin – they have been successfully investing in internationally focused Irish companies for over 25 years, making us the longest established venture capital firm in Ireland. Each of the general partners of the firm has successful commercial investing experience in their own right as well as investing on behalf of EEVC. Their success to date is achieved through investment of capital in well managed, genuinely innovative and growth orientated businesses across a wide range of sectors, focused across the software sector and high technology manufacturing, particularly in the medical device industry. With three funds under management, Enterprise Equity has invested in excess of €50m in over 80 companies throughout Ireland, with many of their founders/companies based in or significantly operating from North America and other locations. In addition, the Enterprise Equity managed AIB Seed Capital Fund is actively investing in founders/companies at the seed or early stage, and the Fund has an overall committed fund size of €53m. EEVC will invest €0.25m to €1.5m per business from this fund. They are regulated by the Central Bank of Ireland under the MiFID Regulations (Markets in Financial Instruments Directive of the European Community). Enterprise Equity’s offices are based in Dublin, Cork, Galway, and Dundalk.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 51
  • Round size: Seed $549k–$2.5M; Series B $2.6M–$7.5M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
  • SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

SciFounders
VC Fund · San Francisco, California, United States · 3 investments in Ireland Medical startups

We invest in highly technical startups from idea-stage up to Series A.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Ireland, United Kingdom

Investor stats

  • Total investments: 14
  • Round size: Seed $3.2M–$5M; Pre-Seed $400k–$400k; Series A $2.5M–$21M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $2.5M in 2024

Portfolio highlights

  • Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
  • Current Surgical — Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
  • Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ascentifi
VC Fund · Galway, Galway, Ireland · 3 investments in Ireland Medical startups

Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 9
  • Round size: Seed $2.3M–$11M; Series A $9.2M–$34M; Venture - Series Unknown $3M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Show all investments...

Medtech Syndicate Nominee
VC Fund · 3 investments in Ireland Medical startups

Medtech Syndicate Nominee

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Seed, Series A
  • Geography: Ireland

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
  • Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
Show all investments...

Diagnostics Polymers
VC Fund · 3 investments in Ireland Medical startups

Investment Fund

Show more...

Investment focus

  • Industry: Medical, Big Data, Health Care
  • Stage:Convertible Note, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $1.2M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

SVG Ventures
VC Fund · Los Gatos, California, United States · 2 investments in Ireland Medical startups

We are a Venture & Innovation Platform Advancing the Food & Agriculture Industries We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the food and agriculture industries.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Farming
  • Stage:Non-Equity Assistance, Seed, Pre-Seed
  • Geography: Canada, United States, Australia

Investor stats

  • Total investments: 314
  • Round size: Seed $100k–$4.7M; Pre-Seed $50k–$100k; Non-Equity Assistance $16k–$40k
  • Lead/follow: 64% lead, 36% follow
  • Last fund: Likely still investing — raised $50M in 2022

Portfolio highlights

  • Robigo — Engineering the plant microbiome for a more sustainable food system
  • Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
  • Brilliant Harvest — Brilliant Harvest is the Most Powerful AI Helpdesk For Equipment Dealers.
Show all investments...

EIT Health
VC Fund · Munich, Bayern, Germany · 2 investments in Ireland Medical startups

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Grant, Pre-Seed, Seed
  • Geography: United Kingdom, Spain, Ireland

Investor stats

  • Total investments: 106
  • Round size: Seed $220k–$1.4M; Grant $27k–$1.6M; Pre-Seed $45k–$1.7M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • IDOVEN — Idoven has developed the world’s first AI cardiologist -Willem- that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale through APIs. The company counts clients such as AstraZeneca, Abbott, Novartis, GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation.Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, EIC Accelerator, Horizon 2020, ERC and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the the European Seal of Excellence 3x from the European Commission, granted by Horizon 2020, European Research Council ERC 2x (RIA) Europe’s most prestigious research grant, supporting excellent researchers in carrying out ground-breaking, high-risk, high-gain, frontier research projects, EIC Accelerator, and EIT Health. Idoven was ranked #1 Spanish HealthTech company in 2020 by NEOTEC. Idoven has been Google for Startups Resident at Google Campus Madrid and part of the Google for Startups Global Alumni Program. The company has won the prize Emprendedor XXI from CaixaBank, the Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine, and has been awarded at South Summit 2021 as the Most Disruptive Startup, and Best Health and Wellbeing Startup. Selected by CB Insights as one of the top 150 global companies in Digital Health for 2022, and top 50 global companies in Digital Health for 2023. Idoven was recognized by TIME Magazine as one of the World's Top HealthTech Companies of 2025.
  • Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Show all investments...

Boole
VC Fund · 2 investments in Ireland Medical startups

Boole

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed
  • Geography: Ireland

Investor stats

  • Total investments: 4
  • Round size: Seed $2M–$4.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Incereb — Incereb is an Irish medical device early stage company in the emerging neonatal intensive care unit (NICU) market. Founded in May 2011, Incereb is headquartered in Dublin, Ireland. The company designs and develops disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products for term and preterm infants (neonates).These intuitive products are designed to be used with minimal training and will significantly reduce the time taken to set up the neonate for EEG and CFM monitoring. Their products are designed to interface with all brands of EEG and CFM recording equipment.Incereb is an award winning early stage company that plans to invest heavily in R&D, product design and development to evolve and extend its product range. Strategic alliances with leading Irish universities and hospitals enable Incereb to leverage home-grown scientific excellence to facilitate fast commercialisation of novel devices leading to rapid growth.
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Show all investments...

Artis Ventures
VC Fund · San Francisco, California, United States · 2 investments in Ireland Medical startups

Artis Ventures has spent over a decade backing bold teams who take the hard path, building market-defining companies to re-shape, re-invent, and re-make industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 153
  • Round size: Seed $2.1M–$35M; Series A $5M–$57M; Series B $18M–$127M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $141M in 2023

Portfolio highlights

  • GenHealth.ai — GenHealth.ai provides healthcare solutions using generative AI trained on encoded medical events. Its product is a generative healthcare AI publicly available. It includes a foundation transformer model (new neural networks with excellent memory), an API, and user applications that can generate and predict future sequences of health events usinghistorical events. Together they can be used to build a large variety of customized applications.
  • Metriport — Metriport helps digital health companies access and manage patient health and medical data, through an open-source and universal API.
  • Ozlo Sleep — Ozlo Sleep is a science-driven sleep and audio technology company that supports and simplifies sleep rituals for clinical benefits, without the use of medication.
Show all investments...

Lynett Capital
VC Fund · San Francisco, California, United States · 2 investments in Ireland Medical startups

Early-stage venture firm backing founders with world-changing potential. Portfolio includes Hadrian, Flutterwave, Onebrief and Long Wall.

Show more...

Investment focus

  • Industry: FinTech, SaaS, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Kenya, Nigeria

Investor stats

  • Total investments: 30
  • Round size: Seed $230k–$3.1M; Pre-Seed $500k–$2.7M; Series A $2.5M–$49M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • idler — Push the frontier of your model
  • Juxta — Juxta delivers infrastructure-free positioning for people, assets, and robots. Track indoors, outdoors, and GPS-denied environments with the Universal Positioning System, Software SDK, and Asset Tags.
  • Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Show all investments...

Life Sciences Fund Amsterdam
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Ireland Medical startups

Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. The fund is a specialist fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects. The close collaboration between the fund, the technology transfer offices of the Life Sciences Centre Amsterdam and the Amsterdam Biomed Cluster, enables the fund to facilitate the transfer of technology to the private sector and to provide emerging technology companies and university researchers with vital seed funding and specialized financial and technical assistance. The fund started in 2007 and is now fully invested.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Private Equity
  • Geography: Ireland, United States, The Netherlands

Investor stats

  • Total investments: 4
  • Round size: Series A $11M–$61M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • HiberCell — Developing therapies targeting adaptive-stress driven vulnerabilities to combat treatment resistance, cancer relapse, and metastasis.
  • Sigmascreening — Pucuk138 merupakan situs andalan Slot88 official gampang gacor dengan bet 100,200 dan 500 perak Auto Maxwin dengan winrate tertinggi.
  • Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
Show all investments...

Glanzmann Enterprises
VC Fund · 2 investments in Ireland Medical startups

Glanzmann Enterprises

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Series A
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in Ireland Medical startups

European Investment Bank operates as the lending institution of the European Union, offering loans, guarantees, and technical expertise to governments, businesses, and financial institutions. The organization focuses on areas such as climate action, digital transformation, housing development, and security-related initiatives. Its activities include funding large-scale infrastructure, supporting technology development, and facilitating access to capital for emerging and established enterprises. The bank also delivers advisory support to structure projects, improve investment readiness, and align initiatives with policy objectives.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Health Care
  • Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
  • Geography: France, Germany, Spain

Investor stats

  • Total investments: 608
  • Round size: Post-IPO Debt $16M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$110M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
  • Dandara Solar Power SAE — Dandara Solar Power SAE is a special purpose vehicle, established to develop a major renewable energy and storage project in Upper Egypt. The entity oversees the development and operational construction of a 500 MW solar PV plant integrated with a 100 MWh Battery Energy Storage System. All electricity generated by the company is bound to be sold to the industrial manufacturer Misr Aluminum Company under a long term, take or pay power purchase agreement.
Show all investments...

Partisan Management Group
VC Fund · Evergreen, Colorado, United States · 2 investments in Ireland Medical startups

Partisan Management Group is a highly successful, early stage venture capital investor in medical device companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: United States, Ireland

Investor stats

  • Total investments: 25
  • Round size: Series A $6.1M–$30M; Series B $16M–$50M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • TriSalus Life Sciences — Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
  • Enable Injections — Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform, a body-worn technology that enables subcutaneous administration of large-volume pharmaceutical and biologic therapies without traditional intravenous methods. The company focuses on engineering devices that allow patients to receive treatmentthrough simple, hands-free injections under the skin while collaborating with pharmaceutical partners to integrate its delivery systems with specific therapies. Its services encompass design, clinical support, manufacturing, and supply of combination products built around the enFuse technology. Enable Injections engages in partnerships to expand application of its delivery systems across varied therapeutic areas and supports regulatory and commercialization planning with its collaborators.
  • Ponce De Leon Pharmaceuticals — PDLHealth researches and commercializes drug-free solutions focused on longevity, healthspan, and the future of aging science.
Show all investments...

Foresight Group
VC Fund · London, England, United Kingdom · 2 investments in Ireland Medical startups

Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices, private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Venture - Series Unknown, Private Equity, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 239
  • Round size: Seed $648k–$7.3M; Private Equity $2.1M–$8.3M; Venture - Series Unknown $979k–$6.5M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: Likely actively investing — fresh fund, raised $120M in 2025

Portfolio highlights

  • Vertal — Vertal is a food waste recycling company
  • nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
  • VS Group — Communications and IT solutions are constantly evolving and changing. We can find a solution that meets your needs and budget.
Show all investments...

Frazier Healthcare Partners
VC Fund · Seattle, Washington, United States · 2 investments in Ireland Medical startups

With its purpose-driven culture and deep industry expertise, the Frazier Growth Buyout team is the preferred partner to profitable healthcare companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Post-IPO Equity
  • Geography: United States, Canada, Ireland

Investor stats

  • Total investments: 184
  • Round size: Series A $10M–$73M; Series B $10M–$110M; Post-IPO Equity $15M–$200M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $2.3B in 2024

Portfolio highlights

  • Simpata — Simpata Inc is a software company that provides its clients with internet-based application services of employee human resources.
  • Nuon Therapeutics — Nuon Therapeutics is focused on the development and commercialization of new therapies in inflammation and neurological diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS) and neuropathic pain.
  • Zeltiq Aesthetics — Learn about the CoolSculpting cryolipolysis procedure.
Show all investments...

Gotzee Ltd
VC Fund · 2 investments in Ireland Medical startups

Holding Company

Show more...

Investment focus

  • Industry: Medical, Big Data, Health Care
  • Stage:Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Round size: Venture - Series Unknown $1.2M–$1.9M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

Oyster Capital Partners
VC Fund · Blackrock, Dublin, Ireland · 2 investments in Ireland Medical startups

Oyster Capital Partners, an Irish private equity firm, specializes in the energy technology, IT, and healthcare sectors.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 21
  • Round size: Seed $1.2M–$4M; Series A $4M–$26M; Venture - Series Unknown $6.5M–$97M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Inclusio — The inclusio diversity and inclusion platform is designed to measure and positively shift the culture of your organisation. Contact us for more information.
  • AICertified — Industry-recognised, accredited AI qualifications built for every learner and organisation.
  • SynergySuite — SynergySuite is an international provider of award winning, cloud based enterprise back office software to leading global restaurant chains. SynergySuite offers a modular solution covering all critical business areas including inventory & procurement, recipe management, food safety, scheduling, cash management, human resources, and businessintelligence. After using SynergySuite our customers add between 4% to 6% per location to their bottom line. SynergySuite has been in the industry since 2011 and works with top restaurant chains like KFC, Macaroni Grill, BrewDog, Hawthorne Leisure and many more across the US, UK, and Ireland.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Ireland Medical startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 141
  • Round size: Series A $6M–$73M; Series B $12M–$92M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $179M in 2024

Portfolio highlights

  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Boole Investment Syndicate
VC Fund · Cork, Cork, Ireland · 2 investments in Ireland Medical startups

Boole Investment Syndicate invests in new technology start-up's with scalability.

Show more...

Investment focus

  • Industry: Biotechnology, SaaS, Software
  • Stage:Seed, Series A
  • Geography: Ireland, Estonia, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $623k–$2.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
  • ArrayPatch — Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
Show all investments...

DHKN
VC Fund · Galway, Galway, Ireland · 2 investments in Ireland Medical startups

Leading Irish accountants providing audit, tax, advisory, payroll and corporate finance services. Offices in Dublin, Cork & Galway. Speak with our experts today.

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Round size: Venture - Series Unknown $6.9M–$7.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ceroflo — Ceroflo offers revolutionary advancement in the treatment of Intracranial Atherosclerotic Disease.
  • Versono Medical — Versono Medical is advancing the development of next-generation CTO crossing solutions.
Show all investments...

Delta Partners
VC Fund · Leopardstown, Dublin, Ireland · 2 investments in Ireland Medical startups

Early stage VC investments and funding for start-ups / founders in Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 116
  • Round size: Seed $812k–$3M; Series A $1.6M–$6.6M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $76M in 2022

Portfolio highlights

  • CleverCards — The Platform for Contactless Cards. The CleverGift real-time payment platform offers gift cards, expenses, employee incentives, and travel foreign exchange.
  • Bloomberg PolarLake — Streamline the acquisition, management and distribution of instrument, pricing, index, legal and ratings data from multiple delivery channels.
  • WhatClinic.com — WhatClinic.com helps patients find, compare and book the right clinics for them, in more than 135 countries. They provide detailed listings for over 120,000 clinics on their site. These include doctors, dentists, beauty and cosmetic surgery, physiotherapy, fertility, holistics and a lot more. They believe that every patient is an empoweredconsumer.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Cantor Fitzgerald
VC Fund · New York, New York, United States · 2 investments in Ireland Medical startups

Cantor Fitzgerald is a global financial services firm that specializes in equities, investment banking, and real estate, fixed income and currencies, prime services, and, affiliates. The firm is known for developing advanced technologies to expand market access, and help clients achieve their most important financial and strategic objectives. This commitment to client-centered innovation has led to enduring relationships with many of the world’s most demanding institutional investors and corporations. The company was founded in 1945 and is headquartered in New York.

Show more...

Investment focus

  • Industry: Biotechnology, Energy, Software
  • Stage:Post-IPO Equity, Debt Financing, Series B
  • Geography: United States, Canada, Ireland

Investor stats

  • Total investments: 23
  • Round size: Series B $6.4M–$36M; Debt Financing $100M–$100M; Post-IPO Equity $12M–$195M
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • FalconX — FalconX is a reliable Institutional Crypto Trading Platform built for financial institutions. We simplify the complex landscape of digital assets and for our institutional clients with seamless price discovery and trade execution strategies at zero slippage and no hidden fees.
  • Semler Scientific — Semler Scientific provides medical technology and software enabling point-of-care testing for early chronic disease detection.
  • Caledonia Mining Corporation — Caledonia Mining Corporation operates as a mining, exploration, and development company focused on Southern Africa. Caledonia's primary asset is a 49% interest in the Blanket Mine in Zimbabwe which produced over 42,800 ounces of gold in 2015 at a cash cost of US$701/oz.Blanket Mine, ZimbabweThe Blanket gold mine re-started production inApril 2009 after a temporary shut-down due to the economic difficulties in Zimbabwe. In late 2010, Blanket successfully completed an expansion project which increased production capacity from 24,000 ounces of gold per annum to 40,000 ounces of gold per annum.As an indigenized entity, Blanket can implement its long term growth strategy. The Blanket board, which includes representatives of the Indigenous Zimbabwean shareholders, approved a capital investment program for a 4 year growth strategy for 2014 to 2017. This investment program, which was endorsed by the Caledonia Board, is estimated at US$65 million, will be funded from Blanket's internally generated cash, and is expected to result in progressive increases in gold production.Blanket is engaged in the exploration of the down-dip extensions of the known ore bodies and the first two satellite exploration projects which are within trucking distance of the Blanket metallurgical recovery plant.Blanket's metallurgical plant has substantial surplus capacity. Increased production arising from increased mining throughput could, therefore, be processed with moderate capital investment and incurring only consumable costs to treat any increased throughput.Caledonia has a strong, experienced management team and Board of Directors with diverse expertise in gold production, exploration, mine development, finance, and marketing. Caledonia's management team is based in Johannesburg, South Africa, and Jersey, Channel Islands.Caledonia paid its initial dividend in February 2012. On April 4, 2013 Caledonia announced an annual dividend in respect of the year to December 31, 2012. On November 25, 2013, Caledonia announced that in 2014 it intends to pay an annual aggregate dividend of 6 Canadian cents per common share, payable on a quarterly basis. The first quarterly dividend of 1.5 Canadian cents per common share was declared and paid in January 2014. Further quarterly dividends have bene paid thereafter. On December 16, 2015, Caledonia announced that henceforth it would report its financial results in United States Dollars. The dividend paid at the end of January 2016 was therefore denominated in United States Dollars. The quarterly dividend of 1.125 US cents is Caledonia's revised policy and represents an annual dividend of 4.5 US cents. The Caledonia Board will continue to review dividends which will depend on the performance of the company and its capital investment requirements.
Show all investments...

Pareto Holdings
VC Fund · Miami, Florida, United States · 2 investments in Ireland Medical startups

Building world-changing companies in sunny Miami

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 631
  • Round size: Seed $880k–$7M; Pre-Seed $125k–$3.5M; Series A $5M–$35M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Ascenix —
  • Lambda Robotics —
  • Procedural Robotics —
Show all investments...

Gaingels
VC Fund · New York, New York, United States · 2 investments in Ireland Medical startups, 71 in the past 12 months

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital to date.  The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 1354
  • Round size: Seed $1M–$8.1M; Series A $5M–$35M; Venture - Series Unknown $72k–$13M
  • Lead/follow: 1% lead, 99% follow
  • Last fund: Likely actively investing — fresh fund, raised $140k in 2026

Portfolio highlights

  • Allara — Allara is your all-in-one virtual care team for hormonal, metabolic & gynecological conditions such as PCOS and Endometriosis.
  • North.cloud — Automate your enterprise-grade cloud finance with zero effort. Our AI reduces your cloud bill by 50% without any risk, contracts, or technical work.
  • Uvi — Uvi provides infrastructure that serves as a context and reasoning layer for enterprise AI agents. The platform resolves internal corporate vocabulary, tracks dependencies, and reconstructs the decision-making intent scattered across disparate systems like Jira, GitHub, and Slack. By unifying data fragments into an integrated knowledge network, it enables AI tools to process query objectives accurately while enforcing existing user access permissions at the retrieval stage.
Show all investments...

Keiretsu Forum Northwest
VC Fund · Seattle, Washington, United States · 1 investments in Ireland Medical startups

Keiretsu Forum is a community of private equity investors, business leaders and entrepreneurs with a network of over 50 global chapters and more than 2,500 investor members.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed
  • Geography: United States, Spain, Canada

Investor stats

  • Total investments: 111
  • Round size: Seed $507k–$3M; Series A $600k–$8M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • iQure Pharma — iQure Pharma preclinical and clinical drug development
  • Levered Learning — Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States.
  • Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Show all investments...

Street Capital
VC Fund · Toronto, Ontario, Canada · 1 investments in Ireland Medical startups

Street Capital Financial Corporation is a Canadian wholesale lending company. As a wholesale lender, Street Capital doesn’t have an expensive branch network and as such can pass those savings to the consumer. Street Capital prides itself on offering consumers competitive products and interest rates with an exceptional level of service.Havingapproved lender status with Canada Mortgage and Housing Corporation (CMHC) Street Capital is able to offer a broad spectrum of residential mortgage financing products to the consumer. Also, since we’re primarily focused on the mortgage broker origination channel, you’re assured that your mortgage will fit your needs comfortably.By continually working to develop innovative lending solutions and working in partnership with your local mortgage brokers, Street Capital is proud to help more Canadians realize their dreams of home ownership and enhancement.

Show more...

Investment focus

  • Industry: Medical, Automotive, Biotechnology
  • Stage:Seed
  • Geography: Ireland, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Biosensia — Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its componentchip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
  • Drive Time Metrics — Drive Time Metrics is developing innovative new revenue streams from connected car data, and helping automotive OEMs monetize their connected vehicle platforms.
Show all investments...

Kreos Capital
VC Fund · London, England, United Kingdom · 1 investments in Ireland Medical startups

Kreos Capital is Europe's largest and leading provider of growth debt to high-growth companies with revenues up to €150 million. Since 1998, as the pioneer growth debt provider across the UK, Western Europe, Scandinavia and Israel: Kreos has completed nearly 450 transactions and committed €1.8 billion in 14 different countries. Kreos has aproven track record of adding value to portfolio companies and helping them to grow with additional capital and flexibility throughout their business cycle whilst working closely with both the portfolio company management team and their equity sponsors.The Kreos global team has extensive debt financing, management and equity investing experience, covering the pan-European market from its locations in London, Tel Aviv and Stockholm.Kreos is a value added partner, able to offer additional capital and more flexibility with lower equity dilution. Kreos's international team has extensive entrepreneurial, debt financing and equity investing experience, covering all local European markets from its locations in London, Tel Aviv and Stockholm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Debt Financing, Series B, Post-IPO Debt
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 128
  • Lead/follow: no public data

Portfolio highlights

  • Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
  • BiolineRx — BioLineRx is building a best-in-class pipeline designed to deliver meaningful therapeutic benefit to patients with certain cancers and rare diseases.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

Moffett Investment Holdings
VC Fund · 1 investments in Ireland Medical startups

Moffett Investment Holdings is an investment firm

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Show all investments...

Venturewave Capital
VC Fund · Dublin, Dublin, Ireland · 1 investments in Ireland Medical startups

VentureWave Capital is an actively managed private equity group that invests in and builds great companies.

Show more...

Investment focus

  • Industry: Health Care, Education, E-Commerce
  • Stage:Seed, Series A
  • Geography: Ireland, Egypt, United Kingdom

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • XOCEAN — Using unmanned surface vessels (USVs), XOCEAN offers turnkey data collection services to Surveyors, Companies and Agencies.
  • Funderbeam — Funderbeam is a funding and trading platform that connects companies and investors to buy and sell equity stakes. The platform allows the founders to gain exposure, legal support, a funding manager, or an investor network. It also allows the investors to take control of their investments and trade anytime they want.The company was founded in 2013as a global data platform for startup companies.
  • iSchool — iSchool is teaching kids from 6 to 18 years old coding and artificial intelligence using STEM-based curriculums.
Show all investments...

Inventages Venture Capital Investment Inc.
VC Fund · London, England, United Kingdom · 1 investments in Ireland Medical startups

Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals,enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 37
  • Lead/follow: no public data

Portfolio highlights

  • Accera — Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.
  • XOLUTION — XOLUTION is the most advanced reclosable beverage container solution. Already in its prototype state, the new XO resealable can won the Can of the Year Award in Dubai in 2009 (Winner Silver - Category Prototype) and was enhanced and refined since, involving extensive market research and field testing. With the can now entering the consumer beveragemarket, they are confident that the product resembles a step forward for XOLUTION in becoming the market leader in this field. XOLUTION GmbH is headquartered in Munich, Germany. In 2008, Marc von Rettberg was named Chief Executive of the company. He joined Christian Bratsch, Vice President R&D, to introduce innovative designs to the beverage packaging industry for reclosable beverage cans.Rettberg and Bratsch established new product design guidelines with a clear focus on values and benefits for the entire supply chain. The innovative beverage can ends were required to offer easy usage to the consumer (intuitive, easy to open and reseal), easy integration for the beverage filler in the existing processes (no major adjustments to the filling line), easy handling for the can maker (XO reclosable can ends based on standard shells), and improved commercialization for the beverage brand (unique branding options). And, of course, the focus was set on providing these benefits at a reasonable overall cost.In 2009, Can Maker Magazine recognized the XOLUTION innovative resealable can with the Silver Award in the Prototype category for the XO-400 reclosable beverage can lid. Since Time-to-Market is a key challenge for all innovators, Rettberg and Bratsch have created a competitive advantage of rapid prototyping and testing capabilities in their Salzburg R&D Center. XOLUTION GmbH is managed by one of the most competent teams in the business. With long-term experiences in their respective fields, their leading specialists guarantee the best coverage of all business areas from prototyping, R&D and product management to trading and distribution. With their knowledge, the XO Resealable Can was successfully converted from a simple vision to a technologically sophisticated product that will have a significant influence on the canned beverage market.
  • Ripple Foods — Ripple Foods offers a nutritious & delicious milk alternative that is 100% dairy-free, vegan, nut-, lactose- & gluten-free. Discover more about Ripple milk!
Show all investments...

EarlyBird
VC Fund · London, England, United Kingdom · 1 investments in Ireland Medical startups

EarlyBird is a postal snacking service that delivers healthy snacks to its users’ doorstep. It provides its users with TasteBox, 5 healthy snacks and 2 unique teas, to help them through the working week. Its TasteBox also contains music and art from up and coming artists. EarlyBird was launched in 2014 and is based in London, England.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Germany, Ireland, Romania

Investor stats

  • Total investments: 9
  • Round size: Series A $3.3M–$25M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Sikoia — Streamline your decision-making with centralized customer data, comprehensive case management, and automated risk evaluation without complicated integrations.
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Goodlegal — Goodlegal is the One-Stop-Shop for all your Legal needs. Get an out-of-the-box Legal Infrastructure Platform to handle all your problems.
Show all investments...

Medical VC funding in Ireland at a glance

Stats across 261 deals from 188 investors.

188
investors
in Ireland Medical startups
261
deals
in Ireland Medical startups
$3M
median round
in Ireland Medical startups
55%
lead investors
lead at least one round
24%
Grant
most common funding stage

Access all 188 VC funds in Ireland Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 188 VC funds investing in Ireland Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists